DA Davidson lifts C3.ai stock target by 75%, sees long-term benefit from Microsoft deal

EditorAhmed Abdulazez Abdulkadir
Published 12/05/2024, 09:19 AM
AI
-

On Thursday, DA Davidson adjusted its financial outlook for c3.ai (NYSE:AI), a leading enterprise AI software provider. The firm raised the price target on the company's shares to $35.00, up from the previous $20.00, while keeping a Neutral rating on the stock. According to InvestingPro analysis, the stock is currently trading above its Fair Value, with shares trading at $37.59.

The adjustment follows a significant surge in c3.ai's share value, which has risen over 50% in the past month, with InvestingPro data showing a remarkable 30.93% year-to-date return and the stock trading near its 52-week high of $39.88. This uptick is partly attributed to the company's recent announcement of a strategic alliance with tech giant Microsoft (NASDAQ:MSFT).

The collaboration is expected to bolster c3.ai's market presence and product development trajectory, though the company currently reports a net loss of $278.17 million over the last twelve months.

DA Davidson acknowledges the potential long-term benefits of the alliance between c3.ai and Microsoft, suggesting that the partnership could enhance the company's future performance. Nonetheless, the firm anticipates that realizing these benefits could present a complex situation for c3.ai's stock in the near term.

The analyst from DA Davidson, while optimistic about the partnership's eventual positive impact, cautions that the immediate effects on the stock may be difficult to navigate. This perspective underpins the decision to maintain a Neutral rating despite the increased price target.

Investors and market watchers are now looking to see how c3.ai's strategic moves, especially its alliance with Microsoft, will unfold and influence its market position and financial performance moving forward. InvestingPro subscribers have access to additional insights, including 12 more ProTips and a comprehensive analysis showing that while the company maintains strong revenue growth of 18.84%, the RSI suggests the stock is in overbought territory.

In other recent news, C3 AI, a leading enterprise AI software provider, has secured a new patent for its generative AI technology, enhancing its position in the AI landscape. This development coincides with C3 AI's mixed financial results for the first quarter, where total revenue met consensus expectations and the company saw a robust 94% year-over-year growth in partner-supported bookings. However, analyst firms Piper Sandler, Canaccord Genuity, and BofA Securities adjusted their price targets for the company, reflecting a cautious outlook.

In corporate governance, C3 AI recently held its 2024 Annual Meeting of Stockholders, resulting in the election of Class I director nominees and approval of executive compensation. Deloitte & Touche LLP was also appointed as the independent registered public accounting firm for the fiscal year ending April 30, 2025.

Despite the mixed financial performance and cautious outlook from various analyst firms, C3 AI continues to reaffirm its financial targets for fiscal year 2025, for both margins and top-line revenue. These are recent developments in the company's performance and outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.